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Based  on  the original observation that L-tyrosine-azobenzene-p-arsonate (RAT) I 
induced specific delayed hypersensitivity in guinea pigs (1), we have shown that this 
small molecule could serve as a carrier for a macromolecular hapten (2). Conjugates of 
RAT and poly-3'-n-glutamic  acid (PGA) raised humoral antibody specific for the PGA 
determinant and cellular immunity directed against the RAT determinant in guinea 
pigs. In addition, prior immunization with RAT potentiated the anti-hapten response 
(2). These observations prompted the conclusion that RAT,  although  having a  mo- 
lecular weight of only 409, is a  true immunogen 
The RAT-PGA conjugates had, on the average, 9-12 RAT groups per mole- 
cule of PGA. In the present communication, we report the preparation and use 
of better defined, small bifunctional antigen molecules composed either  of one 
RAT carrier moiety and one dinitrophenyl (DNP) haptenic group or of two RAT 
moieties, separated by spacers of varying size. These molecules permitted  an 
exploration of the spatial relationships between carrier and hapten required for 
a  humoral antibody response, as well as the question of "self-help." The  latter 
refers to  the  ability of a  carrier determinant  to cooperate in  the humoral  re- 
sponse to a second identical determinant. In addition, the structural features of 
RAT which are essential for immunogenicity have been investigated. 
Materials and Methods 
The names and structures of the compounds used as antigens in this investigation are shown 
in Table I. A detailed description of their preparation and characterization will be published 
elsewhere. All abbreviations used in this manuscript are also defined in Table I. 
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Monofunctional Antigen  Molecules.--L-Tyrosine-azobenzene-p-arsonate  (RAT)  was  pre- 
pared  by coupling diazotized  arsanilic  acid  to  2V-tert-butyloxycarbonyl(t-BOC)-L-tyrosine. 
This procedure invariably produced mono- (orange)  and bls- (purple)  substituted phenol de- 
rivatives, which are conveniently separated  by column chromatography  on Sephadex  G-15 
(Pharmacia Fine Chemicals Inc., Piscataway, N. J.) in dilute solutions of ammonia. This puri- 
fication technique was used for various other derivatives described below, obtained by diazo- 
nium coupling to phenolic compounds. After appropriate purification, the N-protecting group 
was removed with formic acid (3) and the product was lyophilized. The purity of this deriva- 
tive,  as well as all  those described below, was  investigated by thin-layer  chromatography 
(TLC) in a variety of solvents and by high-voltage electrophoresis at several pH values. The 
most useful solvent for investigating the purity of the diazonlum compounds was found to be 
chloroform: methanol:concentrated ammonia  (3: 4: 2).  Invariably, the purple bis-substituted 
phenolic derivatives remained close to the origin, while the orange mono-substituted deriva- 
tives migrated to varying degrees. 
Using similar methods, the following derivatives of L-tyrosine-azobenzene were obtained: 
p-sulfonate  (SAT); p-acetamide  (AAT); p-sulfonamide  (SNAT); p-nitro  (NAT); and p-tri- 
methylammonium chloride (TAT). 
A corresponding  series  of bovine serum  albumin  (BSA)  and  human 7G globulin  (FIGG) 
conjugates of the above diazonium compounds were prepared as described previously (4, 5). 
The  extent  of substitution  in  each product  was  determined  spectrophotometrically,  using 
extinction coefficients obtained from the corresponding tyrosine derivatives. The average sub- 
stitution varied from 4 to 12 chromophores per molecule of BSA or HGG. 
A series of phenolic derivatives in which the aliphatic moiety of tyrosine was varied were 
coupled to diazotized arsanillc acid to provide the following conjugates of azobenzene arsenate: 
p-hydroxyphenyl propionic acid (DRAT), p-hydroxyphenyl acetic acid (ROTFE), p-hydroxy 
benzoic acid (BRAT), p-cresol (RAP), and tyramine  (TRAT). 
6-Amino-caproyl-L-tyrosine-azobenzene-p-arsonate (SAC-RAT) was obtained  by reacting 
N-t-BOC-6-amino-caproic acid  with  L-tyrosine-methyl  ester  using  N-ethyl-NP-(3-dimethyl  - 
aminopropyl)  carbodiimide  (EDC). The methyl ester was  hydrolyzed to yield N-t-BOC-6- 
amino-caproyl-L-tyrosine, which was coupled with diazotized arsanilic acid. After appropriate 
purification, the N-protecting group was removed with formic acid. 
The  corresponding  compound  containing tyramine instead  of tyrosine was  obtained  by 
preparing  N-t-BOC-6-amino-caproyl-tyramine. Reaction with  diazotized  arsanilic  acid  and 
removal of the N-protecting group yielded 6-amino-caproyl-tyramine-azobenzene-p-arsonate 
(SAC-TRAT). 
Bifunctional Antigen Molecules.-- 
DNP-RA T: Direct reaction of tyrosine with 2,4-dinitroflurobenzene (DNFB) yielded bis- 
N,O-2,4-dinitrophenyl  tyrosine which has been shown to give rise to anti-DNP antibody (6), 
undoubtedly because the O-DNP bond is labile to transconjugation with sulfhydryl groups (7), 
which are available in proteins in injected animals. Singly substituted N-DNP-L-tyrosine was 
obtained by reaction of DNFB with L-tyrosine-O-t-butyl ether-t-butyl ester. Subsequent re- 
moval of the protecting groups with formic acid yielded a ninhydrin negative, Pauly diazo- 
positive product, which on TLC plates migrated very closely to N-2,4,6-trinitrophenyl tyro- 
sine and differed  from bis-N, 0-2,4-dinitrophenyl tyrosine and 0-2,4-dinitrophenyl tyrosine. 
Diazonium coupling and appropriate purification to remove the purple bis-substituted  com- 
pound  yielded the desired DNP-RAT product.  The same compound could be obtained  by 
reacting  RAT  with  DNFB  and  chromatographically  separating  the  bis-dinitrophenylated 
by-product. The latter reaction sequence proved to be less satisfactory. 
DNP-SAC-RAT  and  symmetrical RAT  antigens:  Synthesis  of  N-2,4-dinitrophenyl-6- 
amino-caproyl-L-tyrosine-azobenzene-p-arsonate  (DNP-SAC-RAT)  was  achieved  by  EDC 
coupling of DNP-SAC and  L-tyrosine-methyl ester. After hydrolysis of the methyl ester and o 
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diazonium coupling, the product was purified as described above. Solid phase peptide synthesis 
(8) was used, with some modification, to prepare the following compounds: acetyl-(SAC)~-L- 
tyrosine, DNP-(SAC)s-L-tyrosine,  acetyl-L-tyrosyl-SAC-L-tyrosine, acetyl-L-tyrosyl-(SAC)2- 
L-tyrosine, and acetyl-L-tyrosyl-(SAC)3-L-tyrosine. After extensive purification and diazonium 
coupling,  the  following products  were  obtained:  acetyl-(SAC)3-RAT,  DNP-(SAC)3-RAT, 
acetyl-RAT-SAC-RAT, acetyl-RAT- (SAC) s-RAT, and acetyl-RAT- (SAC) s-RAT. 
The SAC  chain is extremely flexible.  In  order to obtain  symmetrical bifunctional RAT 
molecules with a  rigid spacer for better controlled separation of  the two determinants, two 
cyclic RAT compounds, cyclo-L-RAT-L-RAT,  in which the side chains of tyrosine are eis with 
respect to the diketopiperazine ring, and the trans molecule,  cyclo-L-RAT-D-RAT, were pre- 
pared. They were obtained by cyclization of the corresponding tyr-tyr-methyl ester formates 
to diketopiperazines (9), fo]lowed by diazonium coupling. 
All the symmetrical, bifunctional RAT compounds showed the expected molar extinction 
coefficients in 0.1 N sodium hydroxide (4, 5), indicating two azobenzene-arsonate chromophores 
per molecule. In addition to spectrophotometric analysis, which can distinguish between mono- 
and bis-substituted phenolic derivatives as well as determine the number of chromophores per 
molecule, several compounds were quantitatively analyzed for  arsenic. Elementary  analyses 
were performed by Elek Microanalyticai Laboratories, Torrance, Calif. The results were as fol- 
lows: 
(a) t-BOC-SAC-RAT (C26 H36 09 N4 As) : expected 12.01%; found 12.59%. 
(b) t-BOC-RAT  (C20 H23 O8 N3 As): expected 14.73%; found 14.63%. 
(c) DNP-RAT  (C21 His O10 N5 As): expected 13.02%; found 11.75%. 
(d) DNP-SAC-RAT  (C27 H29 Oll N6 As) : expected 10.88%; found 10.94%. 
In the physiologic pH range, the extinction coefficients of the bifunctional RAT compounds 
were low compared to RAT. At pH 7.4  in saline, RAT-SAC-RAT,  cyclo-L-RAT-L-RAT,  and 
cyclo-L-RAT-D-RAT exhibited 32, 34, and 23% hypochromism, respectively. Molecular models 
of these compounds indicated sufficient flexibility to permit the basic centers (-N--N- groups) 
to align intramolecularly with the acidic centers (arsonate groups) in a "deck of cards"  geom- 
etry (10). This intramolecular stacking may serve to reduce the effective bifunctional character 
of  these molecules. 
Animals.--Randomly bred albino guinea pigs weighing about 600 g each were used  in  all 
experiments. 
Immunization.--Antigens  were dissolved in 0.15 ~  sodium chloride, the pH  was  adjusted 
to 7.0,  and the aqueous solutions were emulsified with equal volumes  of complete  Freund's 
adjuvant  (CFA; Difco Labs.,  Inc., Detroit, Mich.). Immunization protocols varied with dif- 
ferent experiments and will be described with the results. 
Delayed Hypersensitivity.--Skin  tests of immunized animals were performed on a  shaved 
area of the flank by intradermal injection of 50-100/zg of antigen in 0.1  ml of saline, pH 7.2. 
Skin sites were examined at 2-4 hr for signs of Arthus reactions and at 24 and 48 hr for de- 
layed reactions. Reactions were considered positive if they consisted of an area of induration 
and erythema 5 mm in diameter or larger. 
Quantitative Precipitin Determinations.--The BSA and HGG conjugates served as test an- 
tigens for detection of specific  antibody. Sera were assayed using a  micromodification of the 
Folin-Ciocalteu method that is useful for determining quantities of protein in the range of  1- 
10 #g, as previously described  (11). 
Lymphocyte Stimulation.  Lymph node or spleen cells were cultured and  their response  to 
antigen was assessed by incorporation of methy]-thymidine-14C (New England Nuclear Corp., 
Boston, Mass.)  into DNA,  as described previously (2). 
RESULTS 
Respone to Bifunctional Antigens Containing  DNP and RAT Determinants.- 
All guinea pigs immunized with antigens containing DNP and RAT responded 1236  MONO-  AND  BIFUNCTIONAL  ANTIGEN  MOLECULES 
with delayed hypersensitivity to RAT and circulating antibody to DNP (Table 
II). None of the animals developed cellular immunity to DNP, assessed by skin 
testing with (DNP)24-BSA. The humoral response to the RAT determinant was 
negligible, compared with the anti-DNP response, based on precipitation with 
(RAT)n-BSA. The efficacy of spacers between the two determinants in facil- 
itating the anti-hapten response was explored by comparing DNP-RAT, DNP- 
SAC-RAT,  and  DNP-(SAC)3-RAT.  Since  each  SAC  chain has  an  extended 
length of about 8 A, the maximum separation of the RAT and DNP determi- 
nants in DNP-SAC-RAT and DNP-(SAC)~-RAT was 8 and 24 A, respectively. 
The anti-DNP responses to these two compounds were identical, within experi- 
mental error. However, although DNP-RAT evoked an anti-DNP response, it 
was significantly weaker than the responses to the DNP-SAC-RAT compounds. 
It was considered possible that the anti-DNP response to DNP-RAT might 
have resulted from transconjugation of the DNP group to other carrier mole- 
cules, such as autologous proteins. DNP-RAT should be less stable than the 
DNP-SAC-RAT compounds because of the approximate position of the DNP 
and  COOH  groups  on the side chain  of tyrosine (TYR),  both  of which  are 
strongly electronegative. In order to test this possibility, animals were immu- 
nized with DNP-TYR, which also contains the two electronegative groups on 
the side  chain,  and  DNP-(SAC),-TYR,  both  of which  lack  carrier  activity 
and fail to induce delayed hypersensitivity. Neither gave rise to anti-DNP  an- 
tibody (Table II),  rendering improbable the transconjugation hypothesis. In 
addition, acetyl (Ac)-(SAC)3-RAT provoked delayed hypersensitivity to RAT 
but no anti-DNP response, as expected (Table II). 
Potentiation of Anti-DNP Response by Prior Immunization with RA T.--For 
these experiments, two groups of four guinea pigs were primed with 0.5 mg of 
(DNP)20-ovalbumin(OVA) administered intraperitoneally in saline on two suc- 
cessive days. 1 wk later, one group was injected with 0.3 mg of RAT in CFA 
distributed between two footpads, while the other group received only CFA ad- 
ministered similarly. After an additional period of 3 wk, both groups received 
0.5 mg of DNP-(SAC)3-RAT in CFA distributed between the other two foot- 
pads, and 0.5 mg of the same antigen intradermally in saline. All animals were 
bled 1 wk later and at weekly intervals thereafter. A comparison of the anti- 
DNP levels of the two groups is shown in Fig. 1.1 wk after administration of 
DNP-(SAC)3-RAT the control group had no detectable circulating anti-DNP 
antibody whereas the group which had been preimmunized with RAT averaged 
35/~g/ml; at 2 wk the values were 30 and 230/~g/ml, respectively. The differ- 
ence at each time interval between the two groups was significant at P  <  0.01. 
Thus, prior immunization with RAT significantly potentiated  the  anti-DNP 
response after immunization with DNP-(SAC)3-RAT. 
Immunogenicity  of Analogs  of RAT Modified  at  the Arsonate  Position.--A 
series of monofunctional analogs of RAT were synthesized and guinea pigs were 
immunized with  each member of the series by a  single injection of 250 #g in ALKAN~ WILLIAMS~ NITECKI~  AND  GOODMAN  1237 
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CFA distributed between the four footpads. The animals were skin tested 15 days 
later and the results are given in Table III. Besides RAT, only the p-sulfonate 
(SAT)  and  p-trimethylammonium  (TAT)  compounds  induced  significant de- 
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Fro. 1. Humoral antibody response to DNP by guinea pigs immunized  sequentially with 
(DNP)20-OVA, RAT,  and DNP-(SAC)3-RAT (upper panel), or with (DNP)20-OVA, CFA, 
and DNP-(SAC)3-RAT (lower panel). There were four animals in each group.  Mean values 
and  standard  errors  are  shown. Differences  between  the  two  groups  were  significant 
at P  <  0.01. 
layed hypersensitivity using this regimen. Of the inactive compounds, only CAT 
carried a charged substituent (carboxylate) at  the arsonate position. Thus,  the 
arsonate group is not essential for immunogenicity of molecules with a  tyrosine- 
azobenzene core, but a charged substituent,  either anionic or cationic, appears 
to be required. ALKAN~  WILLIAMS,  NITECKI,  AND  GOODMAN  1239 
Immunogenicity  of  Analogs  of  RAT  Modified  at  the  Tyrosine  Position.- 
Groups of animals were injected with 250/zg of RAT or equivalent molar quan- 
tities of azobenzene-arsonate  conjugated to various modified tyrosines (Table I). 
The antigens were incorporated in CFA and distributed between the four foot- 
TABLE  III 
Induction  of Delayed Hypersensitivity in Guinea Pigs* by Analogs of RAT Modified at the 
A rsonate Position 
Test antigens 
(RAT) ll-BSA 
(SAT)  2o-B  SA 
(CAT)3-BSA 
(SNAT)5-BSA 
(AAT)4-BSA 
(NAT) 12-B  SA 
(TAT)5-BSA 
RAT 
18§ 
3 
3 
0 
0 
0 
N.D. 
Immunizing agent  ~: 
SAT  CAT 
6  0 
16  3 
5  3 
2  0 
0  0  0  0 
N.  N.D. 
SNAT 
0 
3 
3 
0 
0 
o 
N.D. 
AAT 
0 
2 
2 
o 
0 
0 
N.D. 
NAT 
0 
2 
2 
0 
0 
o 
N.D. 
TAT 
0 
N.D. 
N.D. 
N.D. 
N.D. 
CFA 
* Two animals in each group. No reactions were seen 2 4 hr after  injection of the  test 
antigens. 
:~ See Table I for structures corresponding to abbreviations. 
§ Average delayed skin reaction in millimeters. 
TABLE  IV 
Induction  of Delayed Hypersensitivity in  Guinea Pigs  by Analogs of RAT  Modified at the 
Tyrosine Position 
Immunizing agent* 
Test antigens 
RAT  TRAT  DRAT  ROTTE  BRAT  RAP  CFA 
(RAT)n-BSA  17~(3)§  15(4)  12(7)  13(3)  6(3)  0(3)  0(3) 
(DRAT)4-B  SA  15(3)  20(4)  15(7)  15(3)  2(3)  0(3)  0(3) 
(TRAT)3-BSA  15(3)  17(4)  10(7)  15(3)  2(3)  0(3)  0(3) 
BSA  0(3)  0(4)  0(7)  0(3)  0(3)  0(3)  0(3) 
* See Table I for structures corresponding to abbreviations. 
.~ Averaged delayed skin reaction in millimeters. 
§ Parentheses refer to number of animals tested. 
pads. Skin tests for delayed hypersensitivity were performed 20 days after im- 
munization. The results are shown in Table IV. 
Removal of either the amino group (DRAT) or the carboxyl group (TRAT) 
of  tyrosine did not appreciably diminish immunogenicity, but the compound 
which lacked both charged groups (RAP) did not induce a ~  esponse. Shortening 
the side chain of DRAT by one carbon atom (ROTTE) did not affect immuno- 
genicity, but removal of both methylene groups (BRAT) resulted in a  less po- 
tent inducer of delayed hypersensitivity. 1240  MONO- AND  BIFUNCTIONAL ANTIGEN MOLECULES 
Response to Symmetrical Bifunctional Antigens Containing Two RA T  Determi- 
nants.--The ability of RAT to serve as a carrier for an identical RAT determi- 
nant  was  evaluated  by  immunizing  groups  of  animals  with  a  series  of 
bifunctional  RAT  molecules:  RAT-SAC-RAT,  RAT-(SAC)2-RAT,  RAT- 
(SAC)3-RAT, and cyclo-L-RAT-D-RAT. In the cyclic compound, the spacer is 
more rigid and the arsonate groups are projected on opposite sides of the plane 
of the  ring,  providing  somewhat better controlled  separation  of the  determi- 
nants. Groups of four to eight animals were injected with 0.25, 1.0, or 2.5 mg of 
one of the compounds, administered as before in CFA distributed between the 
four footpads. The animals were bled 10 and 20 days later, skin tested 20 days 
after immunization, and the lymph node cells of some were assayed in vitro for 
stimulation of DNA synthesis by antigen. Most of the animals were bled weekly 
for 3 wk and none developed more than 2 #g of precipitating antibody to RAT, 
TABLE  V 
Humored and Cdlular Responses of Guinea Pigs to RA T-(SA C)z-RA T* 
Test antigens  Average  delayed  Average  lymphocyte  Anti-RAT  skin reaction  stimulation:~  Ab (mean) 
mm  t~g/mt 
(RAT)  n-BSA  18 (8)§  2.4 (2)  <2.0 
RAT- (SAC)  3-RAT  9 (8)  1.6 (2) 
RAT  6 (8)  3.0 (2) 
BSA  0(8)  0,9(2) 
* Animals immunized with 1.0 mg of RAT-(SAC)3-RAT in CFA. 
~" Ratio of thymidine-14C incorporation in cultures with antigen present  relative to cul- 
tures without antigen from the same animal. 
§ Parentheses indicate number of animals tested. 
although  all  developed  cellular  immunity.  The  group  of  animals  immunized 
with 1.0 mg of RAT-(SAC)~-RAT was studied in greatest detail and the data 
from these animals are shown in Table V. All developed strong delayed hyper- 
sensitivity  without  significant  humoral  immunity.  The  lymph  node  cells 
from two of the guinea pigs were assayed for thymidine incorporation and were 
stimulated more than twofold by (RAT)n-BSA and RAT. 
All animals which were immunized with 0.25 mg of RAT and RAT-(SAC)I_~- 
RAT were given a booster injection of 1.0 mg of their respective antigens 6 wk 
after the primary injection and bled 10 days later. As before, the antibody level 
averaged less than 2 tzg/ml. Thus, these symmetrical bifunctional antigens were 
much weaker inducers of humoral immunity than the asymmetric DNP-RAT 
compounds. 
Since the bifunctional RAT compounds were unable to induce a  significant 
primary humoral  anti-RAT response,  their  capacity to promote a  secondary 
response in appropriately prepared subjects was investigated. Eight guinea pigs 
were immunized with 10 ttg of  (RAT)n-BSA  in CFA and all  developed  anti- E 
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arsonate  antibody, determined by precipitation with  (RAT)I~-HGG (Fig.  2). 
30 days later, four animals received 250 #g of RAT in CFA while the other four 
were injected with the same quantity of RAT-(SAC)3-RAT in CFA. The levels 
of anti-arsonate antibody 10 and 20 days later were either unchanged or lower, 
but all animals developed delayed hypersensitivity to RAT. The animals were 
rested until day 90, when the levels of anti-arsonate antibody were very low. 
Challenge at this time with 250 #g of RAT or 200 #g of RAT-(SAC)8-RAT pro- 
duced no increase in these levels (Fig. 2). Consequently, neither RAT nor RAT- 
< 
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FIG. 2. Humoral anti-arsonate antibody response by guinea pigs immunized sequentially 
with (RAT)ll-BSA and RAT (O) or with (RATht-BSA and RAT-(SAC)3-RAT (C)). There 
were four animals in each group. Mean values and standard errors are shown. 
(SAC)3-RAT was able to induce a secondary humoral response in animals which 
had both cellular and humoral immunity to RAT. 
DISCUSSION 
Based on our current understanding of the immune response, the minimum 
requirement/or  a  molecule to function as a  carrier  for a  hapten would be its 
"recognition" by at least one clone of thymic (T) lymphocytes. Large proteins 
function best as carriers,  presumably because they present a diversity of deter- 
minants and so have a high probability of interacting with a number of T  cells 
of different specificity. Small, uni-determinant molecules as a rule are nonimmu- 1242  MONO-  AND  BI]?UNCTIONAL  ANTIGEN  MOLECULES 
nogenic and serve only as haptens. In conjunction with an immunogenic carrier 
they evoke humoral antibody, but  cellular immunity is usually confined to the 
carrier. RAT appears to be an exception in that it can, by itself, evoke cellular 
immune responses such  as delayed hypersensitivity  (1,  2)  and  a  proliferative 
response by sensitized lymphoid cells in culture (2). 
On the basis of the cellular immune response to RAT, it seemed logical that 
it could serve as a carrier for a hapten. This, indeed, proved to be the case when 
RAT was conjugated to a nonimmunogenic macromolecular polypeptide (2)  as 
well as to DNP  (this investigation). In both  instances,  the humoral response 
was predominantly  directed  against  the  haptenic  determinant,  while  cellular 
imnmnity was restricted  to RAT. This functional discrimination between the 
determinants of these synthetic conjugates is highly compatible with a two cell 
mechanism of induction of humoral immunity and has a parallel in the immune 
response to the natural  polypeptide glucagon (12). In the latter investigation, 
it was found that humoral antibody had a predominant specificity for the amino- 
terminal heptadecapeptide,  whereas only the carboxy-terminal undecapeptide 
was capable of stimulating sensitized cells in culture. Thus, there is evidence for 
a functional dichotomy of determinants in both natural and synthetic antigens. 
This does not mean that carrier determinants cannot also function as haptens. 
Proteins  substituted  with  azobenzene-p-arsonate  groups  can  provoke  anti- 
arsonate antibody. However, under circumstances where RAT is joined only to 
a hapten, it appears to function simply as a carrier. Analogously, when glucagon 
was conjugated to a protein carrier,  the carboxy-terminal region behaved like 
a haptenic determinant (13). 
As discussed previously (2), it cannot be rigorously excluded that the activity 
of RAT is due to an indirect mechanism, such as its adherence to a  carrier  in 
vivo and in cell culture. Arguing against such a mechanism are the observations 
that polymers of D-tyrosine-azobenzene-pt-arsonate are inactive  (1)  and  that 
humoral antibody is not elicited by monofunctional arsanilate compounds (1, 2), 
but is by DNP-RAT bifunctional molecules.  In addition,  prior  immunization 
with RAT potentiated the  anti-hapten  response (2; this investigation), as has 
carrier immunization in conventional hapten-protein systems (14,  15).  Indeed, 
all observations made with RAT have parallels in systems in which macromole- 
cules served as carriers. 
A  recent report on  the  immunogenicity of several dinitrophenylated  amino 
acids (6) is in our judgement irrelevant to the findings presented here. The prepa- 
rations is question  always contained O-DNP or N(imidazolyl)-DNP substitu- 
tions which are known to transconjugate in the presence of sulfhydryl groups 
(7). We took great pains to ensure the absence of these labile derivatives from 
preparations used for immunization,  and  our preparations of DNP-TYR and 
DNP-SAC-TYR were inactive (Table II). 
In the work referred to  (6), DNP-SAC  also induced  the formation of anti- 
DNP antibody. In our preparation of this compound by the reaction of DNFB ALKAN~  WILLIAMS~  NITECKI,  AND  GOODMAN  1243 
with 6-amino-caproic acid, a by-product was observed by TLC. It was not pos- 
sible to remove it by eight recrystallizations, but purification was achieved by 
chromatography on very large columns of silica gel. It is not known if this impur- 
ity could have been responsible for the putative immunogenicity of DNP-SAC 
(6), but in our hands DNP-SAC compounds which did not contain azobenzene- 
arsonate were inactive (Table II). 
The use of small, structurally defined bifunctional antigens permitted study 
of the spatial displacement of the two determinants needed to elicit an antibody 
response. A  single SAC  spacer with a  maximum extended length  of 8 A  per- 
mitted as strong an anti-DNP response as a spacer three times that size (Table 
II). These spacers were flexible chains (rigid rods would have been preferable) 
so the effective spacing at the critical time of the response remains hypothetical. 
Joining the two determinants without a  spacer resulted in  a  weaker but still 
pronounced anti-DNP response. It is difficult to visualize how two cells could 
simultaneously interact with so small a molecule, if direct contact between T 
and B  lymphocytes is required. Alternatively, a  soluble mediator released by 
the T  cell which activates the B lymphocyte remains a possibility (16). 
The compounds in which DNP and RAT are separated by spacers should be 
very stable, particularly in the physiologic  pH range. However, DNP-RAT would 
be expected to be less stable because the side chain of tyrosine in this conjugate 
possesses two electronegative moieties, the carboxyl and DNP groups. There- 
fore, it was considered possible that the anti-DNP response to DNP-RAT might 
have resulted from transconjugation of the DNP group to other carriers, such 
as autologous proteins. However, the inactivity of DNP-tyrosine in stimulating 
an anti-DNP response (Table II) appears to effectively vitiate this possibility. 
Since it is unusual  for a  molecule as  small  as RAT to be immunogenic,  a 
systematic exploration of the  structural  features which  contribute to its im- 
munogenicity was  undertaken. A  series of analogs with  substitutions for the 
arsonate group, some members of which carried negatively charged substitu- 
tents  while  others were  neutral  or positively charged,  was  tested.  Only  the 
sulfonate (SAT) and trimethylammonium (TAT) compounds induced delayed 
hypersensitivity with the single immunizing regimen employed. These findings 
suggest that a charged substituent is needed at the arsonate position, but is not 
necessarily sufficient since  CAT  was  inactive,  and  that  either  a  cationic  or 
anionic group may fill the role. It is worth noting that there was little, if any, 
cross-reactivity in  delayed  hypersensitivity between  RAT,  SAT,  and TAT 
(Table III), so different clones of antigen-reactive cells seem to be involved in 
the responses to these immunogens. 
Tests with  the  series  of analogs modified at  the tyrosine position showed, 
again,  the importance of polar groups for immunogenicity. Removal of either 
the carboxyl or amino group from the side chain (TRAT and DRAT, respec- 
tively) did not abrogate the induction of delayed hypersensitivity, but RAP, 
which  carried neither charge,  was  inactive  (Table IV).  Since BRAT,  the p- 1244  MONO-  AND  BII~UNCTIONAL ANTIGEN  MOLECULES 
hydroxy-benzoate compound was palpably less active than DRAT or ROTTE, 
the size of this side chain apparently plays a  part and it will be necessary to 
test compounds with longer uncharged hydrophobic and hydrophilic side chains 
than RAP before the necessity of a charged group at this position can be firmly 
established. 
It is noteworthy that there are several discrepancies between these results 
and those of Leskowitz and his coworkers, who found that RAP induced delayed 
hypersensitivity in  guinea pigs  (1)  whereas  SAT did  not  (17).  One possibly 
significant difference in  protocol was  their use  of more mycobacteria in  the 
preparations  used for immunization  than is  included in  commercial Freund's 
adjuvant.  This  could conceivably account for the  inactivity of RAP  in  our 
hands but obviously would not explain the inactivity of SAT in theirs. 
Monofunctional RAT appears to induce a pure cellular immune response  (1, 
2). There is now a reasonable basis for the view that at least two antigenic deter- 
minants  are required for a  humoral antibody response  (14). The question of 
self-help, whether an immunogenic molecule with two identical determinants 
can provoke a humoral response, remains to be definitely answered. Immuniza- 
tion  with  symmetrical  bifunctional  RAT-RAT  compounds induced  cellular 
inmmnity  without  detectable humoral  antibody,  in  marked  contrast  to  the 
behavior of asymmetric bifunctional DNP-RAT antigens. It might be argued 
that DNP is a  more potent hapten than arsonate, but one would still  expect 
RAT-RAT  to  influence  the  level  of  anti-arsonate  antibody  in  animals  pre- 
treated with (RAT)u-BSA and RAT in order to prepare them for a secondary 
anti-hapten response with a second carrier. Bifunctional RAT antigens had no 
effect on the level of anti-arsonate antibody in such animals (Fig. 2). 
Several conceivable explanations, which are not equally plausible, to account 
for the  inability  of RAT-RAT  compounds  to  engender  a  humoral  response 
might bear consideration. One is that the bifunctional compounds used in this 
study are sufficiently flexible to permit the two determinants to be bound by 
receptors on the same cell surface, thus failing to satisfy the requirement/or 
cell cooperation. Another, related to the first, is that flexibility results in intra- 
molecular stacking of the RAT determinants, compromising their bifunctional 
character. The hypochromism observed with these compounds, including the 
cyclic dityrosine molecules which were expressly prepared for greater rigidity, 
suggests  that  this  occurs  to  a  marked  degree  (discussed  in  Materials  and 
Methods). An approach to this problem is the preparation of bifunctional mole- 
cules with more rigid spacers, which is currently in progress. A third possibility 
is that there is a biological block to self-help. 
SUMMARY 
L-Tyrosine azobenzene-p-arsonate (RAT) induced cellular immunity without 
antibody production in guinea pigs. Bifunctional antigens were prepared con- 
sisting  of  one  RAT  carrier moiety linked  either  directly to  a  dlnitrophenyl ALKAN,  WILLIAMS,  NITECK[,  AND  GOODMAN  1245 
(DNP)  haptenic determinant or through one or more 6-amino-caproyl (SAC) 
spacers. Each SAC unit has an extended span of 8 A. Guinea pigs immunized 
with these conjugates developed cellular immunity directed  against the RAT 
determinant and  antibody specific for the  DNP  determinant. :  The anti-DNP 
response was  the  same with  one or  three  SAC  spacers,  but was significantly 
weaker when the two determinants were joined without a  spacer. Animals im- 
munized with either DNP-SAC-TYR or DNP-TYR developed neither cellular 
nor humoral immunity. Prior immunization with RAT potentiated the second- 
ary anti-hapten response to DNP-SAC-RAT. 
Modification of RAT at either the arsonate or tyrosine positions showed that 
other charged groups (sulfonate and trimethylammonium) could substitute for 
arsonate  without  loss  of  immunogenicity.  Removal  of  either  the  amino  or 
carboxyl group from the side chain of tyrosine did not abolish immunogenicity, 
but immunogenicity was lost upon removal of both. 
Immunization with symmetrical bifunctional RAT-(SAC)n-RAT and  cyclo- 
(L-RAT-D-RAT) antigens led  to cellular immunity but no anti-arsonate anti- 
body, suggesting a barrier to "self-help." These compounds were also ineffective 
in inducing a secondary anti-arsonate response in animals primed with arsonate- 
BSA conjugates and RAT. 
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